BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)

Clinical trial NCT02047110 · COMPLETED

Trial details

NCT number: NCT02047110
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ankylosing Spondylitis (AS)

Start date: 2014-01-28
Primary completion: 2015-03-05
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.